These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Development of HIV protease inhibitors: a survey. Ren S; Lien EJ Prog Drug Res; 1998; 51():1-31. PubMed ID: 9949858 [TBL] [Abstract][Full Text] [Related]
28. Hyperlipidemia associated with the use of protease inhibitors. Smith JH; Martin GJ; Decker CF Clin Infect Dis; 2000 Jul; 31(1):207-8. PubMed ID: 10913432 [No Abstract] [Full Text] [Related]
29. High rebound of plasma and cellular HIV load after discontinuation of triple combination therapy. Jubault V; Burgard M; Le Corfec E; Costagliola D; Rouzioux C; Viard JP AIDS; 1998 Dec; 12(17):2358-9. PubMed ID: 9863885 [No Abstract] [Full Text] [Related]
30. [New drugs, new obstacles in the fight against HIV]. Fonseca MS Sidahora; 1996; ():13-4. PubMed ID: 11364289 [TBL] [Abstract][Full Text] [Related]
32. Norvir capsule approved. AIDS Patient Care STDS; 1999 Sep; 13(9):567. PubMed ID: 10813038 [No Abstract] [Full Text] [Related]
33. Drug approval. AIDS Policy Law; 1999 Apr; 14(8):12. PubMed ID: 11366532 [TBL] [Abstract][Full Text] [Related]
34. FDA notifications. Generic lopinavir/ritonavir approved by FDA. AIDS Alert; 2009 May; 24(5):59. PubMed ID: 19452652 [No Abstract] [Full Text] [Related]
35. FDA approves nelfinavir. Food and Drug Administration. GMHC Treat Issues; 1997 Mar; 11(3):8. PubMed ID: 11364277 [TBL] [Abstract][Full Text] [Related]
36. Health-related quality of life in HIV patients switching to twice-daily indinavir/ritonavir regimen or continuing with three-times-daily indinavir-based therapy. Badía X; Podzamczer D; Moral I; Roset M; Arnaiz JA; Loncà M; Casiró A; Rosón B; Gatell JM; Antivir Ther; 2004 Dec; 9(6):979-85. PubMed ID: 15651756 [TBL] [Abstract][Full Text] [Related]
37. The choice of HIV protease inhibitor: indinavir is currently the best option. Prescrire Int; 1999 Apr; 8(40):55-60. PubMed ID: 10848067 [TBL] [Abstract][Full Text] [Related]
38. Nelfinavir is number 4 -- but should it bat cleanup, or lead off? Mascolini M J Int Assoc Physicians AIDS Care; 1997 Jun; 3(6):17-21. PubMed ID: 11364427 [TBL] [Abstract][Full Text] [Related]
39. FDA notifications. HIV-1 adult treatment guidelines are updated. AIDS Alert; 2006 Jun; 21(6):71. PubMed ID: 16795141 [No Abstract] [Full Text] [Related]
40. FDA clears HIV drug for patients with resistant virus. AIDS Read; 2006 Aug; 16(8):392. PubMed ID: 16933372 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]